Bli medlem
Bli medlem

Du är här

2016-08-30

Prothena Corporation plc: Prothena to Participate in Upcoming September Investor Conferences

DUBLIN, Ireland, Aug. 30, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc
(NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the
discovery, development, and commercialization of novel protein
immunotherapies, today announced that members of its senior management team
will present and participate in several upcoming investor conferences:

* Credit Suisse Antibody Day on September 7, 2016 at 12:00 PM ET in New York,
NY
* Citi's 11th Annual Biotech Conference on September 8, 2016 in Boston, MA
* Morgan Stanley Global Healthcare Conference on September 12, 2016 at 8:45
AM ET in New York, NY
* The Ladenburg Thalmann 2016 Healthcare Conference on September 27, 2016 at
10:00 AM ET in New York, NY

A live webcast of the company presentations can be accessed under the
Investors tab in the Events and Presentations section of the Company's
website at www.prothena.com. Following the live presentations, a replay of
each webcast will be available on the Company's website for at least 90 days
following the presentation date.

About Prothena

Prothena Corporation plc is a global, late-stage clinical biotechnology
company seeking to fundamentally change the course of progressive diseases
with its clinical pipeline of novel therapeutic antibodies. Fueled by its
deep scientific understanding built over decades of research in protein
misfolding and cell adhesion - the root causes of many serious or currently
untreatable amyloid and inflammatory diseases - Prothena has advanced several
drug candidates into clinical trials while pursuing discovery of additional
novel therapies. Our pipeline of antibody-based product candidates targets a
number of potential indications including AL amyloidosis (NEOD001),
Parkinson's disease and other related synucleinopathies (PRX002) and
inflammatory diseases, including psoriasis (PRX003), and ATTR amyloidosis
(PRX004). For more information, please visit the company's web site at
www.prothena.com.

For more information, please visit the company's web site at www.prothena.com.
Contacts
Investors: Tran Nguyen, CFO
650-837-8535, IR@prothena.com

Media: Ellen Rose
650-922-2405, ellen.rose@prothena.com

---------------------------------------

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Prothena Corporation plc via Globenewswire

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.